I want to talk about something bigger than one test and one bill today — because that’s really what the ASAP Act is about. 

Right now, Alzheimer’s is largely invisible in our health care system until late in the disease. By the time most people are diagnosed, they already have dementia — even though the disease has been building for ten, fifteen, twenty years. That’s not a failure of patients, families or clinicians. They’re working with the tools they’ve had. What’s changing now is the tools. 

Here’s the part that gets me excited: once blood tests happen at scale, Alzheimer’s becomes visible in our system in a way it never has been. Doctors get a new tool. Health systems get data they can’t ignore. And patients get diagnosed early enough to actually participate in decisions about their own care. I walk through why that matters in this week’s episode of the ASAP Minute. 

▶ Watch Episode 12: Screening Starts a Revolution 

Think about what happened with breast cancer — it wasn’t just that screening rates went up, it’s that breast cancer became visible, survivorship became a movement, and the whole culture of care changed. That’s what’s possible here: primary care catching Alzheimer’s earlier, treatment pathways expanding, research getting real-world data it’s never had. 

This is how we start treating Alzheimer’s like cancer, heart disease or diabetes — caught early, treated early. And that’s a future every family touched by this disease deserves to be part of. 

Tell your member of Congress it’s time for a system that catches Alzheimer’s early.